Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence between Divalproex Sodium ER
Tablets 500 mg of Dr. Reddy's and Depakote ER 500 mg Tablets of Abbott Laboratories in
healthy, adult, human subjects, under fed conditions and to monitor adverse events and ensure
the safety of subjects.